Oxford BioMedica plc (OXBDF)
OTHER OTC:OXBDF
Holding OXBDF?
Track your performance easily

Oxford BioMedica (OXBDF) Financial Statements

57 Followers

Oxford BioMedica Financial Overview

Oxford BioMedica's market cap is currently ―. The company's EPS TTM is $-1.811; its P/E ratio is -3.04; Oxford BioMedica is scheduled to report earnings on September 23, 2024, and the estimated EPS forecast is $-0.37. See an overview of income statement, balance sheet, and cash flow financials.
Jun 22Dec 21Jun 21Dec 20Jun 20
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT-----
EBITDA-----
Net Income Common Stockholders-----
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments£ 118.51M£ 109.02M£ 61.27M£ 46.98M£ 50.62M
Total Assets£ 466.70M£ 237.23M£ 197.69M£ 183.93M£ 160.19M
Total Debt£ 107.50M£ 9.34M£ 9.73M£ 13.85M£ 10.62M
Net Debt£ -11.01M£ -99.68M£ -51.54M£ -33.14M£ -40.00M
Total Liabilities£ 206.69M£ 49.89M£ 65.08M£ 71.18M£ 51.35M
Stockholders Equity£ 222.03M£ 187.34M£ 132.60M£ 112.75M£ 108.84M
Cash Flow-
Free Cash Flow-----
Operating Cash Flow-----
Investing Cash Flow-----
Financing Cash Flow-----
Currency in GBP

Oxford BioMedica Earnings and Revenue History

Oxford BioMedica Debt to Assets

Oxford BioMedica Cash Flow

Oxford BioMedica Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis